4th Annual NASH Roundtable Virtual Forum

Thursday, November 18, 2021 | 11:30 AM PST | 2:30 PM EST

On-demand video recordings will be available soon.


11:30 AM PST | 2:30 PM EST

Welcome Remarks and Introduction

Marcus Hompesch, MD

President & CEO, ProSciento, Inc. and Editor-in-chief, Endocrinology, Diabetes & Metabolism

Rohit Loomba, MD

Professor of Medicine, Director of Hepatology, at University of California at San Diego and Founding Director of UCSD NAFLD Research Center

Key Takeaways from the AASLD Liver Meeting

Utilizing NASH PASS® Biobank for Biomarker Discovery and Translational Research

Julio Gutierrez, MD

Vice President of Clinical Research and Clinical Science, ProSciento, Inc. and Transplant Hepatologist at Scripps Health


Biomarkers of Hepatic Fibrosis, Fibrogenesis, and Fibrosis Resolution

Morten Karsdal, PhD

Chief Executive Officer, Nordic Bioscience A/S

Advances in Imaging Technologies for Fibrotic Diseases – A Look Forward

Lars Johansson, PhD

Chief Scientific Officer, Antaros Medical AB


Collaborative Translational Research Opportunities Utilizing the NASH PASS® Biobank

Arun J. Sanyal, MD

Professor, Division of Gastroenterology, Hepatology and Nutrition, at Virginia Commonwealth University School of Medicine

1:00 PM PST | 4:00 PM EST

Roundtable Discussion


2:00 PM PST | 5:00 PM EST

Meeting Conclusion


Hosted By

NASH roundtable
Antaros Medical logo
Nordic Bioscience logo

This event will be recorded and available for viewing approximately one week after the live event.

About NASH Roundtable

NASH Roundtable is a forum of leading hepatologists, endocrinologists and clinical development experts stewarding advances in science, clinical research and therapeutics for nonalcoholic fatty liver disease and steatohepatitis.

For questions or additional information please contact nashroundtable@prosciento.com or visit nashroundtable.com